AIMMAX THERAPEUTICS INC

Novel Anti-Infectives and Anti-Inflammatories

Durham, United States · Founded 2022

Employees
1–10
Founded
2022
Business Model
B2B
Last Round
GrantApr 2025
Rounds
4

About

AimMax Therapeutics is a biopharmaceutical company focused on discovery and development of novel anti-infective and anti-inflammatory therapies. The company's pipeline includes treatments targeting resistant bacteria, fungi, and other microorganisms, as well as an ophthalmic corticosteroid formulation that received FDA NDA approval in March 2024.

Summary

AIMMAX THERAPEUTICS INC is a Biotech company based in Durham, United States, founded in 2022. Its most recent funding was a Grant round in Apr 2025. Investors include Department of Health and Human Services.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantApr 2025

Sign up to see all 4 rounds

Seed through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AIMMAX THERAPEUTICS INC on Indexed.vc
<a href="https://indexed.vc/companies/aimmax-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/aimmax-therapeutics-inc" alt="AIMMAX THERAPEUTICS INC on Indexed.vc" width="260" height="76" /></a>